Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fey

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Molecular Biology & Medicine|June 1, 1990
Production of interleukin 6 by hepatoma cellsW Northemann, M Hattori, G Baffet, et al.
Blood|February 7, 2004
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allograftsPeter Lang, Karin Barbin, Tobias Feuchtinger, et al.
Genomics|July 1, 1991
The Interleukin-6-dependent DNA-binding protein gene (transcription factor 5: TCF5) maps to human chromosome 20 and rat chromosome 3, the IL6 receptor locus (IL6R) to human chromosome 1 and rat chromosome 2, and the rat IL6 gene to rat chromosome 4J Szpirer, C Szpirer, M Rivière, et al.
Journal of Translational Medicine|November 19, 2013
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2Todd A Braciak, Sarah Wildenhain, Claudia C Roskopf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cellsYvonne Guettinger, Karin Barbin, Matthias Peipp, et al.
Cancer Letters|February 23, 2011
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cellsChristian Kellner, Joerg Bruenke, Heike Horner, et al.
Oncotarget|August 14, 2014
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cellClaudia C Roskopf, Christian B Schiller, Todd A Braciak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16Heiko Singer, Christian Kellner, Harald Lanig, et al.
The Journal of Biological Chemistry|January 5, 1987
Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNAM R Gehring, B R Shiels, W Northemann, et al.
Mabs|February 14, 2012
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Molecular Biology & Medicine|June 1, 1990
Production of interleukin 6 by hepatoma cellsW Northemann, M Hattori, G Baffet, et al.
Blood|February 7, 2004
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allograftsPeter Lang, Karin Barbin, Tobias Feuchtinger, et al.
Genomics|July 1, 1991
The Interleukin-6-dependent DNA-binding protein gene (transcription factor 5: TCF5) maps to human chromosome 20 and rat chromosome 3, the IL6 receptor locus (IL6R) to human chromosome 1 and rat chromosome 2, and the rat IL6 gene to rat chromosome 4J Szpirer, C Szpirer, M Rivière, et al.
Journal of Translational Medicine|November 19, 2013
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2Todd A Braciak, Sarah Wildenhain, Claudia C Roskopf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cellsYvonne Guettinger, Karin Barbin, Matthias Peipp, et al.
Cancer Letters|February 23, 2011
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cellsChristian Kellner, Joerg Bruenke, Heike Horner, et al.
Oncotarget|August 14, 2014
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cellClaudia C Roskopf, Christian B Schiller, Todd A Braciak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16Heiko Singer, Christian Kellner, Harald Lanig, et al.
The Journal of Biological Chemistry|January 5, 1987
Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNAM R Gehring, B R Shiels, W Northemann, et al.
Mabs|February 14, 2012
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
Pageof 19